A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation

NCT00148148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation
Fungus Diseases

Interventions

DRUG: caspofungin
DRUG: liposomal amphotericin B

Sponsor

University Hospital Muenster

Collaborators

[object Object]
[object Object]